Background: Idiopathic scoliosis is a spinal deformity affecting approximately 3% of otherwise healthy children or adolescents. The etiology is still largely unknown but has an important genetic component. Genome-wide association studies have identified a number of common genetic variants that are significantly associated with idiopathic scoliosis in Asian and Caucasian populations, rs11190870 close to the LBX1 gene being the most replicated finding.
Introduction
Idiopathic scoliosis is a spinal deformity affecting approximately 3% of otherwise healthy children or adolescents. In approximately 10% of the affected individuals, the deformity is progressive, requiring treatment with brace or spinal fusion surgery [1] .
The etiology of idiopathic scoliosis is still largely unknown; heredity, however, is an important contributing factor [2, 3] . Recent genome-wide association studies have identified common genetic variants close to, or within, the ladybird homeobox 1 (LBX1), cell adhesion molecule L1-like (CHL1), and G protein-coupled receptor 126 (GPR126) genes, as well as an intergenic variant on 17q, in Asian and Caucasian populations [4] [5] [6] [7] . One exome sequencing study has identified novel, rare variants associated with idiopathic scoliosis in the Fibrillin 1and 2 genes in a European population [8] . However, these variants explain only a small part of the heritability of this disorder. The aim of the present study was to investigate the genetics of idiopathic scoliosis in a Scandinavian cohort by performing a candidate gene study of variants previously shown to be associated with idiopathic scoliosis and exome sequencing of idiopathic scoliosis patients with a severe phenotype.
Methods
This is a Swedish and Danish multicenter case-control study. Five Swedish and one Danish orthopedic department participated: the Karolinska University Hospital, the Skåne University Hospital, the Sahlgren University Hospital, the Sundsvall and Härnösand County Hospital, and the University Hospital of Umeå, all in Sweden, and Middelfart Hospital, Denmark.
Subjects and samples collection Cases
Between 2004 and 2013, individuals with idiopathic scoliosis were invited to participate in the study. Details of the recruitment of patients have been published elsewhere [9] [10] [11] . Inclusion criteria were a juvenile or adolescent idiopathic scoliosis with a Cobb angle greater than or equal to 10° [12] . Only patients with a normal neurologic examination and without history or clinical sign of a non-idiopathic scoliosis were eligible for the study. A magnetic resonance imaging (MRI) was not mandatory for inclusion in the study, but all cases with an MRI of the spine showing neural abnormalities were excluded. In total, 4,404 patients were invited; 1,244 did not answer, 955 declined to participate, and 320 were excluded because of signs of nonidiopathic scoliosis, incomplete medical records, or age at onset less than 4 years of age, leaving 1,885 individuals for this study. Sampling and DNA extraction was successful in 1,739 patients, Table 1 .
Among the 1,739 patients, 495 were untreated, 641 were brace treated, and 603 were surgically treated. To allow for grading of the severity of the scoliosis, curve size was measured on routine radiographs from the occasion when the patient was considered to have the largest curve size: The last available radiograph before the age of 27 years in the untreated patients; on the last radiograph before bracing in the brace-treated patients; and on the preoperative radiograph in the surgically treated patients. Measurements were performed by the method by Cobb [12] and showed a mean (standard deviation) of 25 (12) for untreated, 33 (8) for braced, and 57 (14) ° for operated patients. Curve location was defined according to the apex of the major curve; thoracic curves had an apex between the first and eleventh thoracic vertebrae, thoracolumbar curves between the twelfth thoracic and first lumbar vertebra, and lumbar curves from the second lumbar to fifth lumbar vertebrae. If an individual had two curves with a difference between the two measurements of less than 5°, the patient was defined as having a double primary curve. Individuals who were aged 4 to 9 years old at onset of scoliosis were defined as having juvenile idiopathic scoliosis. Of the patients, 1,485 (85%) had parents who both were born in Scandinavia, 109 (6%) had one parent who was born in Scandinavia and one parent who was born outside Scandinavia, 113 (6%) had parents who were both born outside Scandinavia, and in 35 (2%), data on place of birth of parents were not available.
DNA was prepared from blood in 98% and saliva in 2% of the samples. In 1,216 patients, a salt precipitation method on the Autopure LS system (Qiagen, Hilden, Germany) was used, and in 523 samples, the QIAamp 96 DNA Blood Kit (Qiagen, Hilden, Germany) was used for DNA extraction according to instructions from the manufacturer.
From this cohort, 100 patients with a severe phenotype and Swedishancestry were chosen for exome sequencing, Table 1 . Additional DNA was extracted with the Gentra Puregene Blood Kit (Qiagen, Hilden, Germany) according to instructions from the manufacturer. Concentration of the DNA was measured at least twice with the Qubit dsDNA BR Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA). An equal amount of DNA from each subject was added to make 10 pools, with DNA from 10 patients in each pool.
Controls Osteoporosis Prospective Risk Assessment (OPRA) and PEAK-25 cohorts
Individuals from the population-based cohorts OPRA and PEAK-25 were used as controls [13, 14] . The OPRA cohort consists of elderly women, and the PEAK-25 cohort consists of young women living in Malmö, Sweden. Deoxyribonucleic acid was available in 2,011 individuals. In both these cohorts, dual-energy X-ray absorptiometry (DXA) for studying bone density had been part of the research protocol. Dual-energy X-ray absorptiometry has been reported to be a reliable method to evaluate scoliosis, comparable to conventional radiographs [15] . However, DXA is performed with the patient in a supine position, and the Cobb angle may be underestimated compared with standing radiographs. We therefore chose to exclude all individuals showing any sign of a curved spine on a whole body or lumbar spine DXA (n=199). We included those individuals missing DXA information (n=69), because the prevalence of idiopathic scoliosis in the normal population is low [1] , leaving 1,812 individuals for this study, Table 1 .
In the 909 controls from the OPRA cohort, data on place of birth of parents were not available. All except three were born in Sweden. Place of birth is not specified for two individuals. In the 903 controls from the PEAK-25 cohort, 833 (92%) had parents who both were born in Scandinavia, 49 (5%) had one parent who was born in Scandinavia, and 21 (2%) had parents who both were born outside Scandinavia. Deoxyribonucleic acid was extracted using the QIAamp 96 DNA Blood Kit (Qiagen, Hilden, Germany) according to the instructions from the manufacturer.
Control data for exome sequencing
We used already existing anonymized exome sequencing data from 100 preeclampsia patients [16, 17] and 100 patients with morbid obesity [18] as control data for the exome sequencing, Table 1 . There is no phenotype information on scoliosis for these controls. The same pooling strategy, target enrichment, and sequencing platform as in the present study were used in both these cohorts.
Candidate gene study Genotyping
We genotyped the previously reported variants rs10510181, rs11190870, rs12946942, and rs6570507 in 1,739 patients with idiopathic scoliosis and in 1,812 controls from the OPRA and PEAK-25 cohorts [4] [5] [6] [7] . Genotyping was performed at the Mutation Analysis Facility at Karolinska University Hospital (Huddinge, Sweden) using iPLEX Gold chemistry and MassARRAY mass spectrometry system (Agena Bioscience, San Diego, CA, USA) [19] . Multiplexed assays were designed using the MassARRAY Assay Design v4.0 Software (Sequenom, Agena Bioscience, San Diego, CA, USA). Genotype calls were manually checked by two persons individually using the MassARRAY Typer v4.0 Software (Agena BioScience, San Diego, CA, USA).
Sequencing of LBX1 locus
We found a strong association to rs11190870, approximately 6 kb downstream of the LBX1 gene. To further study the role of LBX1 in idiopathic scoliosis, we chose to sequence the LBX1 promoter and exon regions. There are two known transcripts of LBX1, one confirmed (NM_006562) and one predicted (XM_005269443), described in the Genome Reference Consortium, human reference 38, Figure S1 . The coding regions of the confirmed transcript were covered by exome sequencing, in the following section. The predicted transcript (XM_005269443) of LBX1 contains an extra noncoding exon that was not covered by the exome sequencing target enrichment platform that we used. According to the FANTOM5 human promoter centric expression atlas, there are three transcription start sites (TSSs) of LBX1 and one TSS of the new LBX1isoform, detected in both adult and fetal skeletal muscle, Figure S2 [20] . To cover the new noncoding exon and the TSSs, we designed three primer pairs and performed polymerase chain reaction (PCR) amplification with HotStarTaq Plus DNA Polymerase kit (Qiagen, Hilden, Germany) on genomic DNA from the 100 pooled samples used in exome sequencing, Table 1 . PCR products were sequenced using cycle sequencing technology on ABI 3730XL sequencing machine at Eurofins Genomics (Ebersberg, Germany).
Exome sequencing
Exome sequencing was performed at the Science for Life laboratory, Stockholm, Sweden. Each DNA library was prepared from 3 µg of pooled genomic DNA sheared to 300 bp using a Covaris S2 instrument (Covaris, MA, USA) and enriched using the SureSelectXT Human All Exon 50 Mb (Agilent technologies, CA, USA) and an Agilent NGS workstation according to the manufacturer's instructions (SureSelectXT Automated Target Enrichment for Illumina Paired-End Multiplexed Sequencing, version A; Agilent technologies, CA, USA).
Sequencing data analysis and variant selection
Exome sequencing reads were aligned to the human reference genome hg19, Genome Reference Consortium Human Build 37, with the Burrows-Wheeler Aligner, BWA software package, version 0.6.1 (http://sourceforge.net/projects/bio-bwa/files/bwa-0.6.1.tar.bz2) [21] . We used SAMtools, version 0.1.18 (http://sourceforge.net/projects/samtools/files/samtools/0.1.18/), to remove PCR duplicates on each lane, filter out reads with low mapping quality (Phred quality score <20), and call variants [22] . Both single and multiple pool calls were used. Annotation was completed using the ANNOVARsoftware (Biobase, Wolfenbuettel, Germany) [23] . We applied BEDTools, version 2.16.2 (http://bedtools.readthedocs.org/) for read depth and coverage evaluation [24] .
We estimated the minor allele frequency of each variant by pooling all the reads at each position together and calculating the percentage of reads supporting the minor allele. We filtered out singleton variants and selected missense, nonsense, and splice site rare variants that had a minor allele frequency less than or equal to 0.05 in the 1000G project European population [25] . We compared our data with the exome sequencing data from the 100 preeclampsia and the 100 obesity patients. We filtered out the variants that were found in more than one of the preeclampsia and obesity pools as likely innocent variants or sequencing errors. Among the remaining variants (n=353), we selected those that were related to skeleton, muscle or nervous system development, or cell adhesion (n=29) in the Gene Ontology Consortium database [26] . In addition, we checked the 353 variants by manual visualization and kept those not shown in obesity or preeclampsia patients at all (n=21).
Variant validation and association analysis
In an initial validation association analysis, 45 of the variants selected from the exome sequencing were successfully genotyped in 180 cases, including the previously exome sequenced subjects, and in 245 controls from the PEAK-25 cohort. In a follow-up, 20 of the variants with an odds ratio (OR) greater than or equal to 1.5 or less than or equal to 0.67 in the initial association analyses were genotyped in the remaining 1,567 cases and 1,567 controls from the OPRA and PEAK-25 cohorts. The same genotyping platform was used as described previously for the candidate gene study, Table S1 . Finally, an association analysis combining the two data sets was performed.
Statistical analysis
Association was evaluated by the chi-square test using PLINK v1.07 (http://pngu.mgh.harvard.edu/purcell/plink/) [27] . For subgroup analyses, curve severity was defined as mild if the patient had a Cobb angle of 10° to 30°, moderate if the patient had a Cobb angle of 31° to 44°, and severe if the patient had a Cobb angle greater than or equal to 45°. Patients with a thoracic major curve with a right convexity were defined as "Right Thoracic" and patients with a thoracic major curve with a left convexity as "Left Thoracic." The group "All Except Right Thoracic" includes all patients except those defined as "Right Thoracic." Patients were subgrouped according to the age at onset in 4 to 8, 9 to 12, and 13 years and older, as well as in juvenile (4-9 years) and adolescent (10-20 years).
Results

Association analysis of candidate genes
Of the four candidate genes, only an intergenic variant, rs11190870, downstream of the LBX1 gene, showed a strong association to idiopathic scoliosis in individual genotyping of cases and controls, Table 2 . The other three variants showed weaker or no association. In subgroup analyses of the association of rs11190870, there seemed to be a stronger association with females than males, and with right thoracic curve types compared with all other curve types together, yielding higher point estimates for the ORs, Table 3 . The curve severity and juvenile or adolescent age of onset did not appear to have a significant effect on the association, Table 3 . However, comparisons between patient subgroups did not yield significant differences (data not shown). In addition, when comparing untreated, brace-treated and surgically treated individuals, we found no significant differences in association with the risk allele.
We analyzed age at onset as a continuous outcome variable in a logistic regression of cases only and found no significant association with the risk allele (data not shown). In a subgroup analysis comparing age at onset 4 to 8 years, 9 to 12 years, and 13 years and older, we found no significant differences in association with the risk allele either (data not shown).
Sequencing of LBX1 locus
Because we observed a highly significant association of the previously identified LBX1 variant to scoliosis, we performed Sanger sequencing to discover further genetic variation at this locus. We did not find any variants in the 5′UTR, noncoding exon or promoter regions of LBX1, data not shown.
Exome sequencing
We obtained 307 to 418 million sequence reads in each sample pool, 93.3% to 98.5% of which could be mapped to the human reference genome hg19. Eighty-one to eighty -nine percent of the SureSelect target regions were covered by a depth of 30x. We identified a total of 1.7 million single nucleotide variants. After filtration and an initial genotyping validation, we selected 20 novel variants for further follow-up. We were, however, unable to find statistically significant association of any of these to idiopathic scoliosis in the large cohort of 1,739 cases and 1,812 controls, Table S1.
In the LBX1 exon region, we identified one synonymous variant, rs941909, in 6 of the 10 pools in the idiopathic scoliosis patients and in 8 of the 10 pools in the preeclampsia patients, suggesting that it is a common innocent variant (data not shown).
Discussion
In a candidate gene study of four common single nucleotide variants previously shown to be associated with idiopathic scoliosis, we found a highly significant association of rs11190870, downstream of the LBX1 gene (p=7.0×10−18, OR 1.53) to idiopathic scoliosis, in a Scandinavian cohort of 1,739 idiopathic scoliosis cases and 1,812 controls. The other three variants showed weaker or no association. To identify novel high-risk variants contributing to scoliosis, we then performed exome sequencing on 100 pooled samples with a severe idiopathic scoliosis phenotype. Multiple variants were identified by exome sequencing, but we could not verify any association to idiopathic scoliosis by direct genotyping in the cohort of 1,739 cases and 1,812 controls. No new functional variant in the LBX1 gene was found. In addition, we Sanger sequenced the promoter region of LBX1 without identifying any variants.
In a genome wide association study, Takahashi et al. [5] identified the common variant rs11190870 in the 10q24.31 region to be strongly associated with idiopathic scoliosis in a Japanese population of 1,033 cases and 1,473 controls with a p value and OR (1.2×10−19 and 1.56, respectively) in parity with the present study. This association has subsequently been replicated in several North American and East Asian cohorts, suggesting the region on 10q24.31 harboring the LBX1 gene, to be a true susceptibility locus for idiopathic scoliosis [28] [29] [30] . In this study, we found a highly significant association of rs11190870 to idiopathic scoliosis also in a Scandinavian population, and as such, confirm the association of the region 10q24.31 to idiopathic scoliosis across populations.
Of the remaining three variants genotyped in our study, two showed a weak association to idiopathic scoliosis (rs6570507, p=1.6×10−4, OR 1.22 and rs12946942, p=.005, OR 1.27). The variant rs6570507 has previously been shown to be associated with idiopathic scoliosis in Japanese, Chinese Han, and European populations (p=1.27×10−14, OR 1.27) and rs12946942 in a Japanese and Han Chinese population (p=6.43×10−12, OR=2.21) [4, 6] . Our results lend support to the previously observed associations at a moderate level of genetic effect, but these variants do not appear to have a major effect on scoliosis risk in the Scandinavian population. Because of an obvious lack of power, we did not follow up subgroup associations to these three variants in the present study. LBX1 is expressed in dorsal spinal neurons and hindbrain, muscle precursor cells, and certain cardiac crest cells and is a plausible candidate in the pathogenesis of idiopathic scoliosis [31] [32] [33] [34] [35] . In an attempt to further elucidate the potential role of LBX1 in idiopathic scoliosis, we used the FANTOM5 database to identify four putative TSSs of LBX1, detected in both adult and fetal skeleton muscles. We Sanger sequenced these regions in pooled DNA from 100 surgically treated idiopathic scoliosis patients. We were, however, unable to identify any variants in these regions.
The variant rs11190870 seems to be associated to idiopathic scoliosis irrespective of scoliosis curve severity [28] [29] [30] . This is supported by our findings, where we found no substantial differences in OR between mild, moderate, or severe scoliosis compared with controls. In a previous meta-analysis of several cohorts, Londono et al. [30] showed evidence for genetic susceptibility to scoliosis of rs11190870 in both males and females. In the current cohort, including the largest number of males reported, the point estimate of risk is higher in females, but not significantly different compared with that in males. In addition, the association of rs11190870 seems to be as strong in both adolescent and juvenile idiopathic scoliosis patients as well.
Patients with idiopathic scoliosis have normal neurology and no signs of any disorders associated with scoliosis. However, MRI may reveal subclinical neural axis abnormalities in these patients. The most common curve type is a right convex thoracic scoliosis and it is most often associated with a normal neural axis MRI. On the other hand, neural axis malformations have been reported to be more common in left thoracic curves, and it may be speculated that these may represent another clinical entity [36, 37] . Based on this, we hypothesized that the genetic basis could be different in patients with different curve types. In a subgroup analysis, we found that the association of rs11190870 seems to be stronger to right thoracic curves than all other curve types taken together (1.4×10−19, OR 1.68 and 5.4×10−5, OR 1.32, respectively) and to patients with left thoracic curves. The number of patients in the latter group is however very small, limiting the conclusions that can be drawn. To our knowledge, data on association with curve types have not been presented previously.
The variants previously shown to be associated with idiopathic scoliosis, in other studies and ours, explain only a small part of the heritability of idiopathic scoliosis. To identify novel rare high-risk variants, we exome sequenced 100 pooled samples from individuals with a severe idiopathic scoliosis. The variants we identified were validated but were not strongly associated by individual genotyping in our large cohort of 1,739 and 1,812 controls. In addition, we could not find any putative functional variants in the LBX1 gene. In a recent exome sequencing study of a European population, rare variants in Fibrillin 1 and 2 were found to contribute to scoliosis [8] . We could not replicate these findings (data not shown). This might be due to different population background or different selection of subgroups of scoliosis individuals.
A limitation of the pooled exome sequencing strategy is the need for filtering. Variants found in only one pool and variants with a very low frequency, despite being found in several pools, were removed to avoid false positives. One might question the use of exome sequencing data from morbidly obese and preeclampsia patients without any scoliosis phenotype information as control data. However, the prevalence of scoliosis is low in the general population, and an above-normal BMI is shown to be protective against spinal deformities [38] . Another limitation is the difficulty of finding association by genotyping of the variants identified by exome sequencing. This might be due to a lack of power in the follow-up, looking for rare variants demands large sample sizes to reach significance.
In conclusion, we confirm LBX1 as a susceptibility gene for idiopathic scoliosis in a Scandinavian population and do not find evidence of other scoliosis risk genes of similar or stronger effect. In the future, possible strategies to succeed in elucidating the role of the LBX1 region and discovering new risk factors for adolescent idiopathic scoliosis, include metastudies, detailed studying of subphenotypes, family studies, and epigenetic approaches. Tables   Table 1 
